Here, we have shown that within cancers that bear BRAF mutation, the mutually exclusive nature of mutations in these genes remain, indicating that the mutual exclusivity is likely between APC and RNF43 mutations, rather than between BRAF mutations and APC mutations. This evidence concerns the gene RNF43 and cancer.